Robotics and AI in Laboratory Research
Search documents
Ginkgo Bioworks Reports Fourth Quarter and Full Year 2025 Financial Results, Announces Focus on Autonomous Labs Offerings and Divestiture of its Non-Core Biosecurity Business
Prnewswire· 2026-02-26 21:26
assets—5,796121,404Deferred income tax benefit(1,364)(936)(801)Loss on disposal of equipment—844842Non-cash lease expense30,08228,09528,313Non-cash in-process research and development—19,7969,182Accretion of discount on marketable securities(3,390)——Other non-cash activity2,0641,2243,194Changes in operating assets and liabilities:Accounts receivable ($357, $156 and $816 from related parties)(1,473)(4,725)50,068Prepaid expenses and other current assets(5,247)10,08510,473Operating lease right-of-use assets3,8 ...